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Stem cells are central to developing new treatment options for tissue regeneration and constructing control-
lable models for biological research. Bioengineered cell culture environments that combine microenviron-
mental control with tissue-specific transport and signaling are critical tools in our efforts to study tissue
development, regeneration, and disease under conditions that predict the human in vivo context. We
propose that experimentation at the interfaces of biology, engineering, and medical sciences is critical for
unlocking the full potential of stem cells. Here, we focus on the design and utilization of in vitro platforms
that recapitulate the environments associated with tissue development, disease, and regeneration.The regenerationofwornanddiseased tissuesusingsomeformof
cell therapy is becoming increasingly plausible. The need is
obvious. Medical advances have extended the functional life of
our organs and enabled us to live longer and better. It has been
estimated that roughlyone in fivepeople reachingageof 65would
benefit from some kind of tissue replacement therapy during their
lifetime (Lysaght and Reyes, 2001). At this time, tissues that are
failing beyond repair or missing due to surgical resection or
congenital abnormalities are being replaced by transplantation,
an ultimate measure limited by the scarcity of matching donor
organs. Recent advances in stem cell biology and tissue engi-
neering are enabling us to ‘‘instruct’’ multipotent cells—the
ultimate ‘‘tissue engineers’’—to differentiate into the right pheno-
types in the right place and at the right time in order to assemble
functional tissue structures. It is a true integration of biology and
engineering that makes it possible to design ‘‘biomimetic’’ envi-
ronments that subject the cell to the combinations of factors
known to guide tissue development and regeneration in vivo.
We are just starting to fully realize the importance of the entire
context of a cell’s microenvironment, including the presence of
other cells, three-dimensional matrix, and sequences of molec-
ular and physical morphogens. The premise behind the design
of biomimetic models is that to unlock the full potential of stem
cells, at least some aspects of the dynamic in vivo environments
need to be reconstructed in experimental systems used in vitro.
It has been argued that we now need a new generation of 3D
culture systems that would offer a middle ground between the
bare bones approach of a standard Petri dish and a live organism
model, such as a rat or mouse (Lutolf, 2009; Burdick and Vunjak-
Novakovic, 2009). Advanced culture systems that combine high
biological fidelity with tight control over the cellular environment
are in active development and have begun to take center stage in
efforts to define stem cell responses that predict their behavior
in vivo. By definition, the development of biomimetic environ-
ments depends on replicating the physiological context, based
on an existing knowledge of the in vivo conditions present in
a target organ or tissue. However, productive, functional artificial
environments may also be constructed according to lessons
learned from the in vivo settings, without aiming to fully recapit-
ulate those conditions. Indeed, it is increasingly possible, and
sometimes may be necessary, to generate engineered tissues252 Cell Stem Cell 8, March 4, 2011 ª2011 Elsevier Inc.by going beyond a purely biomimetic context toward a set of
conditions that promote organ and tissue regeneration to the
extent achievable without external manipulation.
Overall, research at the interface between stem cell science
and tissue engineering is currently driving important advances
into the regeneration of functional tissue structures. The two
communities—biologists and engineers—have been discon-
nected for a very long time but are now starting to effectively
communicate in order to establish an entirely new interdisci-
plinary field of stem cell bioengineering. In fact, some of the
most exciting recent breakthroughs in regenerative medicine
have been achieved by integrating stem cell science with the
application of bioengineering methods (Petersen et al., 2010;
Ott et al., 2010; Grayson et al., 2009; Macchiarini et al., 2008;
Uygun et al., 2010; Zimmermann et al., 2006). At the same
time, bioengineering research is becoming focused on funda-
mental biological questions that cannot be addressed using
the traditional cell culture plates (Altman et al., 2002; Au et al.,
2007; Connelly et al., 2010; Discher et al., 2009; Freytes et al.,
2009; Gilbert et al., 2010; Hui and Bhatia 2007; Lucchetta
et al., 2005; Lutolf et al., 2009; Lutolf, 2009; Nelson et al.,
2005; Park et al., 2009; Skelley et al., 2009; Terraciano et al.,
2007). The bioengineered stem cell ‘‘niche’’—comprising
multiple cell types, extracellular matrix, cytokines, and physical
factors—has emerged as a new paradigm for stem cell research
that brings together the two communities in amost effective way.
The implications of this collaborative approach are yet to be
seen but are likely to extend beyond the current goal of
answering complex biological questions using new bioengi-
neering tools, to the derivation of entirely new, as-yet-unfore-
seen concepts that will shape future advances in regenerative
medicine. In this Perspective article, we focus on the develop-
ment and use of biomimetic platforms that provide the interface
between biological questions and engineering tools toward (1)
new insights into environmental regulation of stem cells, (2) study
of disease, and (3) developing new treatment modalities for
regenerative medicine (Figure 1).
Cells
Access to cells, both in sufficient numbers and with the appro-
priate developmental potential, for use in bioengineering has
Figure 1. Bioengineering Platforms
The work at the interface between stem cell
science and bioengineering is now resulting in
controllable models of high biological fidelity that
are driving progress in three major areas: (1) new
treatment modalities for regenerative medicine,
(2) study of development and disease, and (3)
fundamental biological research.
Cell Stem Cell
Perspectivehistorically been limiting. However, two parallel developments
indicate that this issuemay be becoming less problematic. There
have been numerous advances in understanding the hierarchy of
cells comprising particular tissues. Tissues are typically orga-
nized such that mature cells are generated and replaced by a
proliferative pool of less differentiated progenitors, which in
turn arise from a reserve set of stem cells that is relatively small
is size. In the past, the presence of tissue-specific stem/progen-
itor cells had been hypothesized, but the phenotype of these
cells was often not well defined, making their isolation chal-
lenging. The last decade has seen an explosion in the identifica-
tion of stem/progenitor populations in multiple somatic tissues
such that it is now possible to define with precision some key
stem/progenitors in the skeleton, muscle, brain, intestine, skin,
and blood (Barker et al., 2007; Cotsarelis et al., 1990; Frederik-
sen et al., 1988; Sacchetti et al., 2007; Sherwood et al., 2004;
Snippert et al., 2010; Kiel et al., 2005; Osawa et al., 1996; Rietze
et al., 2001). Many of these advances have been achieved using
animal models, and human correlates are still being sought.
Nonetheless, that work is ongoing and likely to be productive.
Identification of adult, multipotent stem/progenitor cells for
use as a source of lineage-committed mature cells may foster
the creation of engineered tissue constructs, at least for situa-
tions in which a pool of precursors is both accessible and can
be grown in a robust fashion. This concept is perhaps best
demonstrated by the isolation and expansion of mesenchymal
stem cells, which can be cultured in order to produce sufficiently
large numbers of cells capable of giving rise to multiple mesen-
chymal lineages. These mature, long-lived progeny can then be
incorporated into engineered constructs (Pereira et al., 1995;
Jaiswal et al., 1997) or even tissues. However, for some tissues,
the existence of an adult stem cell pool is still under debate (such
as in pancreatic islets) (Dor et al., 2004; Smukler et al., 2011) orCell Stem Celthe tissue-specific stem cells may be
in a relatively inaccessible location, such
as in brain, which makes them either
impossible, or at least challenging, to
isolate for ex vivo expansion purposes.
For these tissues, pluripotent stem cells
remain the best option.
Access to pluripotent stem cells repre-
sents the second recent development
that has had a significant impact on
the growing potential of bioengineering
applications. Pluripotent stem cells
(which are capable of making any intra-
embryonic cell type) can now be obtained
not only from blastocysts as embryonic
stem cells (ESCs), but also in the form ofinduced pluripotent stem cells (iPSCs), following the reprogram-
ming of adult somatic cells. The ability to convert a mature skin
fibroblast or blood cell to a pluripotent cell represents an extraor-
dinary achievement that has opened the possibility of generating
cells from the individual who is the intended recipient of a bioen-
gineered construct (Takahashi et al., 2007). The reprogrammed
pluripotent cells appear to be no longer constrained by the ‘‘Hay-
flick limit’’ (Hayflick, 1979). That is, reprogrammed cells are not
subject to the same constraints of senescence that a more
mature cell population encounters, and their final numbers are
essentially unlimited. The generation of large numbers of cells
for use in engineered constructs is therefore made possible.
Those cells may now be generated from the patient so that either
engineered models of disease or engineered therapeutics with
reduced risk of immunologic rejection can be constructed
(Saha and Jaenisch, 2009).
The ability to take full advantage of the inherent potential of
iPSCs depends upon two important issues. First, reprogram-
ming methods that do not result in permanent genetic alteration
of the resulting cells must be developed in order to mitigate the
risk of tumor formation. Recent studies using RNA-based strat-
egies have moved the field markedly closer to that goal (Warren
et al., 2010). Second, it will be necessary to achieve high-fidelity
means for directing the differentiation of iPSCs to tissue-specific
stem/progenitor and mature cells. Mapping of the molecular
signatures of individual cell lineages during their maturation
process is an ongoing area of investigation that will provide
better guidance in selecting the desired features of target cell
populations (Guenther et al., 2010; Bernstein et al., 2010;
Novershtern et al., 2010). By combining molecular signatures of
the various cell states within a lineage hierarchy with larger scale
screening strategies, it is becoming possible to define methods
for differentiation, or even reprogramming to a particular celll 8, March 4, 2011 ª2011 Elsevier Inc. 253
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et al., 2011; Borowiak and Melton, 2009).
Scaffolds
In vivo, cells are surrounded by an extracellular matrix (ECM) that
is responsible for the multidimensional and long-range ordering
of highly organized tissues and that interacts with the local cell
populations and their secreted factors. Disease processes are
often characterized by inappropriate cell-mediated remodeling
that leads to unbalanced turnover of the ECM and negatively
affects local cell function. Three-dimensional scaffolds present
an engineered, in vitro alternative to the native extracellular
matrix for the expansion and organization of cultured cells. A
scaffold can be considered as a structural and ‘‘cell-instructive’’
template for cells and the forming tissue (Burdick and Vunjak-
Novakovic, 2009). Scaffoldmaterials—inmost cases biodegrad-
able and custom-designed to mimic the matrix of a specific
tissue—can be processed into a range of 3D architectures suit-
able for cell seeding and cultivation (Dawson et al., 2008; Nair
and Laurencin, 2007).
The specific choice of biomaterial for any given application is
guided by the need to restore cell-matrix interactions, direct
cell alignment and migration, and apply physical signals (such
as flow-induced shear, mechanical stretch, or electrical pacing).
The Discher lab demonstrated that stem cells specify lineage
and commit to phenotypes with extreme sensitivity to elasticity
of the substrate (Engler et al., 2006), such that soft matrices
that mimic brain are neurogenic, stiffer matrices that mimic
muscle are myogenic, and the stiffest matrices that mimic
bone are osteogenic. The results of their studies significantly
improved our understanding of how physical factors influence
stem cell differentiation.
Advanced scaffold designs are now being developed to imple-
ment patterning, binding of ligands, sustained release of cyto-
kines, and the structural and mechanical anisotropy intrinsic to
specific tissues, such as heart muscle or bone (Engelmayr
et al., 2008; Kloxin et al., 2009; Zhao et al., 2011). A ‘‘biomimetic’’
scaffold would mimic the properties of a native tissue, dynami-
cally interact with the cells by generation and transmission of
biophysical signals, and undergo gradual replacement by newly
synthesized tissue matrix.
Bioreactors
In a Petri dish, the cell culture environment is determined by
the concentrations of oxygen, nutrients, and metabolites
surrounding the cells that all change between one exchange or
refresh of media solution to another. In cultures of 3D tissues,
these concentrations will also change in space, because of diffu-
sion gradients across the thickness of the tissue. In particular,
oxygen penetration depth can be as little as 100 mm for dense
tissues, such as heart or bone. To overcome these limitations
of static culture plates, bioreactors can be developed to provide
control over the cell environment (through enhancedmass trans-
port to and from the cells) and physical signals (hydrodynamic,
mechanical, and electrical) and also to enable insight into cellular
behavior (through imaging and online measurements). Design of
a tissue engineering bioreactor should ideally support cell
viability and 3D organization by mechanisms similar to those
present in the native cell environment (Griffith and Swartz,254 Cell Stem Cell 8, March 4, 2011 ª2011 Elsevier Inc.2006). When designing a bioreactor, we aim at mimicking an
in vivo cell niche (Burdick andVunjak-Novakovic, 2009). In reality,
bioreactors provide an opportunity to manipulate and control
only certain aspects of a given niche but do allow for quantitative
studies of cellular interactions with their environment.
Biosynthetically active cells are central to any of our efforts to
grow tissue grafts, to construct models of disease, or to develop
in vitro platforms for therapeutic screening. In order to mobilize
their full biological potential, the scaffold-bioreactor system
should serve as an in vitro mimic of the milieu of the develop-
ment, regeneration, or disease under investigation. Such a bio-
logically inspired approach is behind the design of highly special-
ized, tightly controlled culture systems that are replacing the
conventional ‘‘one size fits all’’ Petri dishes. With the capability
to generate spatial gradients of regulatory signals, to subject
cells to dynamic changes in their environment, and to offer
insight into cellular responses in real time, these new technolo-
gies are setting a stage for an entirely new approach to stem
cell research. The examples that follow illustrate some of the
recent work at the interface between biology and engineering.
Biomimetic Paradigm
During development and regeneration, tissues emerge from
coordinated sequences of stem cell renewal, specialization,
and assembly that are orchestrated by cascades of environ-
mental factors. In vitro and in vivo, stem cell fate and function
are regulated by a combination of the intrinsic genetic (and
epigenetic) program of the cell, and the cellular microenviron-
ment, also termed a ‘‘niche.’’ Cells interact with the entire
context of their environment, rather than with one single domi-
nating factor (Figure 2). The four main groups of key factors—
(1) regulatory molecules (oxygen, nutrients, cytokines), (2) other
cells (3D context, cell-cell contacts, autocrine and paracrine
signals), (3) extracellular matrix (immobilized and released
factors, structure, topology, stiffness), and (4) physical factors
(flow shear, compression, stretch, electrical signals)—act in
concert, with synergistic and competing effects.
The overall complexity of cell regulation is further increased by
the dynamic nature of regulatory signals, which change in space
and time, and in ways that are not entirely known. Also, the inter-
actions between the cells and their environment occur in both
directions. Cells both respond to and actively modify the proper-
ties of their environment by synthesizing or degrading the extra-
cellular matrix, secreting cytokines, and communicating with
other cells and matrix by molecular and physical signals. The
‘‘dynamic reciprocity’’ (Nelson and Bissell, 2005) of cell-cell
and cell-matrix signaling takes place at multiple hierarchical
levels, from the scale of cell membrane molecules to tissues
and whole organs. At each level, there are specific readouts
that change from one level to another and from one cell or tissue
type to another.
The study of the individual and combined effects of regulatory
signals, via precise spatiotemporal control of signal type and
magnitude, is not a trivial task and certainly not achievable by
using traditional well plates. Recent developments in cell-culture
technology offer the opportunities of singling out one factor of
interest from other systemic signals and superimposing this
factor with other, well-defined signals. Clearly, in vitro systems
cannot possibly capture the complexity of actual regulatory
Figure 2. Biomimetic Paradigm
Stem cell fate and function are regulated by the entire context of the cellular microenvironment (niche), through dynamic interactions of the cells with cascades of
multiple factors: molecular, structural, and physical. Native-like (biomimetic) cell environments can be engineered by a combined use of a scaffold (providing
a structural and logistic template for cell differentiation and functional assembly) and a bioreactor (providing environmental control, molecular signaling, and
physical signaling).
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and controllable studies of multiple factors regulating develop-
mental processes. A biomimetic approach to the formation of
engineered tissues was established to direct the differentiation
and functional assembly of stem cells by factors known to
regulate cell fate and function during native development and
regeneration. Acting in concert, the two components of a tissue
engineering system—scaffold andbioreactor—provide a control-
lable environment for cultured cells, with a multitude of cytokines
(diffusing or immobilized) and physical factors (hydrodynamic
shear, mechanical stretch, electrical gradients) (Figure 2).
Both in vivo (during development and regeneration) and in vitro
(for tissue engineering), the cues presented to cells are principal
determinants of their phenotype. Hence, the designs of systems
for cell culture, cell delivery, and tissue engineering are neces-
sarily inspired by biology (in a developing or adult organism).
The complementary engineering principles help recapitulate
the combinations of parameters in the native environments of
a specific tissue or organ, in order to orchestrate the conversion
of ‘‘collections of cells’’ into specific tissue phenotypes.
Microbioreactors
Microtechnologies have been developed to preciselymanipulate
the cellular microenvironment and study cellular responses in
real time and in a quantitative fashion. Such a small scale allows
for high-throughput studies within a large experimental space
while utilizing minimal amounts of cells and materials. In one
set of recent studies (Figallo et al., 2007; Cimetta et al., 2009),
a simple and practical device was developed by coupling a
microfluidic platform with an array of culture wells to enable
systematic and precise variation of mass transport and hydrody-
namic shear in cultures of human ESCs. This microarray biore-actor with twelve culture wells on a standard microscope slide
format was designed to accommodate stem cells attached to
a 2D substrate and cells encapsulated in 3D hydrogel. Both
culture formats allow for controlled perfusion of medium and
tight control of medium composition and hydrodynamic shear.
Using this microfluidic platform, hESCs were systematically
studied for their cardiovascular differentiation potential. Cell
differentiation correlated with the level of hydrodynamic shear
and transport rates of oxygen and growth factors (Cimetta
et al., 2009). As this technology is compliant with standard
imaging formats, differentiation patterns can be studied with
the aid of quantitative image processing (Figallo et al., 2007).
Another microfluidic device was developed to enable cultiva-
tion of adherent murine ESCs over a range of flow rates, with
concentration gradients applied across the culture space.
Medium composition was precisely controlled through mass
transport of individual molecular species to and away from the
cells. For the first time, mESCs were cultured in continuous,
logarithmically scaled perfusion for 4 days, with more than
a 3000-fold variation in flow rates across the array (Kamei
et al., 2009). The associated hydrodynamic shear was shown
to determine the size of cell colonies. Subsequently, another mi-
crofluidic platform was developed for semiautomated cultivation
of hESCs in a way that allowed parallel study of cell self-renewal
and differentiation using a large parameter matrix.
Microfluidic Platforms
Another application of ‘‘tiny technologies’’ is for themanipulation
of individual cells in culture. Cell fusion is a key event during
embryonic development, and this process has been used to
study the epigenetic reprogramming of somatic cells to pluripo-
tent stem cells. The use of cell fusion as a research tool is rapidlyCell Stem Cell 8, March 4, 2011 ª2011 Elsevier Inc. 255
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Drosophila) into human stem cells. A major challenge in studies
of cell fusion is the low efficiency and specificity of cell pairing.
Random cell aggregation and fusion result in heterogeneity of
cell aggregates, which in turn translates into heterogeneity of
the resulting cellular responses. A recent design of a microfluidic
device may overcome this problem, by achieving efficiencies of
cell pairing of up to 70%, by specifically pairing only two cells
and by performing cell pairing in a high-throughput fashion
(Skelley et al., 2009). The design is remarkably simple, and it is
based on cell trapping into small ‘‘niches’’ by manipulating
flow streams. This approach has great potential for systematic
study of cell reprogramming by fusion.
An elegant early example of the use of microfluidic technology
is the study of the response of theDrosophila embryo to dynamic
perturbation of temperature (Lucchetta et al., 2005). Embryos
were cultured in a Y-shaped chamber that operates with two
fluid streams maintained at different temperatures and allows
on-line imaging of the fluid flow and the embryo. This way, the
anterior and posterior halves of the embryo were forced to
develop at two different temperatures, resulting in different rates
of development. This study exemplifies how microfluidic tech-
nology allows controllable ‘‘perturb and observe’’ experiments
involving complex biological phenomena.
The use of microfluidic technologies is now extending to the
generation of concentration gradients of cytokines in cultures
of stem cells. Spatial gradients of diffusible signaling molecules
are known to determine cell migration, lineage specification,
and maturation during development and are of paramount
interest to human stem cell research efforts. A microfluidic plat-
form of this kind was designed to expose the cultured cells to
stable concentration gradients for more than a week, with only
minimal handling and no external power source (Park et al.,
2009). The gradient wasmaintained by a combination of osmotic
and capillary action. To demonstrate the utility of the system,
hESC-derived neural progenitors were cultured for 8 days with
exposure to gradients of Shh, FGF8, and BMP4. Neural progen-
itors successfully differentiated into neurons, generating a
complex neural network. The average numbers of neuronal cell
body clusters and neurite bundles were directly proportional to
Shh concentrations.
Bioengineering a Cell Niche
Tissue viability and function depend upon regulated replenish-
ment of differentiated cells, through cell propagation, differenti-
ation, and architectural organization. Coordinating these pro-
cesses occurs at multiple levels but must begin with stem/
progenitor cells. Without preservation of these cells and balance
of their self-replenishment versus production of maturing cells,
tissue integrity cannot be maintained. Regulation of stem cells
has been associated with a stem cell niche. All cells engage
with other cells and extracellular environments, but the regula-
tion of cell fate is perhaps most exquisite for the stem/progenitor
cells. Therefore, cell niches have generally focused on the stem
cell niche, an anatomically definable tissue site where self-
renewal and differentiation of stem cells is regulated (Voog and
Jones, 2010).
Understanding in detail the components and physiology of
stem cell niches is still quite limited. There has been progress256 Cell Stem Cell 8, March 4, 2011 ª2011 Elsevier Inc.with a number of tissues (Hsu et al., 2011; Sato et al., 2011),
but the complexity of niche inputs is still best defined for bone
marrow hematopoiesis. It is now clear that multiple cell types
and extracellular components participate in altering the number,
proliferative activity, and localization of stem cells. It is also clear
that thinking of a niche as a single cell type or single matrix
component is too simple and that physiologic regulation
depends upon multiple and often countervailing influences.
Among these are cues from multiple mesenchymal populations
(from undifferentiated cells to osteogenic to adipocytic cells),
hematopoietic descendents such as osteoclasts and macro-
phages, and sympathetic neurons (Calvi et al., 2003; Zhang
et al., 2003; Kollet et al., 2006; Naveiras et al., 2009; Omatsu
et al., 2010; Winkler et al., 2010; Katayama, et al., 2006). In
addition, extracellular matrix glycoproteins (like osteopontin),
signaling and small molecules (like ionic calcium and oxygen)
all appear to play a role (Adams et al., 2006; Nilsson et al.,
2005; Parmar et al., 2007; Stier et al., 2005). Recapitulating this
system in vitro is extremely challenging. However, progress is
being made using constructs of reduced complexity.
It has long been known the hematopoietic stem cell (HSC)
preservation and differentiation can occur on adherent ‘‘stomal’’
feeder layers. Refining these methods based on knowledge of
the endogenous cell niche has been moving forward, now
enabling relatively robust coculture systems that can be used
in intermediate-throughput chemical screens. In addition, highly
promising engineered 2D and 3D niche models have been
developed by the laboratory of Helen Blau (Lutolf et al., 2009).
Usingmicropatterned hydrogels of varying properties containing
growth factors, function of hematopoietic and, dramatically,
muscle stem cells can be modulated. In the latter case, altering
the elasticity of the hydrogel substrate to more closely mimic the
conditions found in vivo, resulted in self-renewal of muscle stem
cells ex vivo such that they were then effective sources ofmuscle
upon transplantation (Gilbert et al., 2010). These results strongly
support the notion that recapitulation of some elements of the
in vivo niche can be productively used to increase stem cell
number and provide useful cell populations for either transplan-
tation of subsequent participation in bioengineered devices.
Micropatterning to mimic architectural relationships in vivo has
also been shown to result in tissue morphogenesis ex vivo that
may be the basis for the reconstruction of complex tissues
(Nelson et al., 2006).
Directed Stem Cell Differentiation
Scaffold-Bioreactor Systems
In a pioneering bioengineering study, hESCs were cultured in
porous alginate scaffolds using a hydrodynamically active biore-
actor under conditions that promote the formation of embryoid
bodies (EBs) and subsequent vascular differentiation (Gerecht-
Nir et al., 2004). The confining environment of scaffold pores
resulted in the formation of small, uniformly sized EBs, each in
a scaffold pore (Figures 3A and 3B). Once differentiation factors
were introduced, these same EBs underwent vascular differenti-
ation. Control of EB size, for example by micropatterning fol-
lowed by suspension culture, proved beneficial for scaling up
cell differentiation to large cell numbers (Niebruegge et al., 2009).
Various types of hydrogels have been developed over the last
decade for propagation and early differentiation of hESCs. The
Figure 3. Scaffold-Bioreactor Systems for Human Stem Cells
(A–E) hESCs were cultured in porous alginate scaffolds using a rotating bioreactor (A) to form spatially defined EBs inside scaffold pores. (B) An anatomically
correct bone graft in the exact size and shape of a human temporomandibular joint condyle (reproduced with permission from Gerecht-Nir et al., 2004) (C)
has been engineered by using an anatomically shaped decellularized bone scaffold (D) seeded with human mesenchymal stem cells and cultured with medium
perfusion (E) in an ‘‘anatomical’’ bioreactor (F) (C–F reproduced with permission from Grayson et al., 2009).
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placed by cell-friendly macromolecules (such as hyaluronane)
(Gerecht et al., 2007) that encapsulate viable cells by photopoly-
merization, have tailored structural and mechanical properties,
and can incorporate functional groups or control-release micro-
carriers (Ferreira et al., 2007). Insights into the dynamics of
cell-matrix interactions helped derive design requirements for
cell culture scaffolds (Engler et al., 2006, 2008; Guilak et al.,
2009; Discher et al., 2009).
New technologies are emerging in conjunction with the use of
new hydrogels to enable precise and systematic variation of
environmental factors in high-throughput settings (Underhill
and Bhatia, 2007; Flaim et al., 2005; Figallo et al., 2007). Overall,
the hydrogel-bioreactor platforms provide unique ways to study
the role of stem cells as mediators of repair. It will be most inter-
esting to see how effectively we can translate these in vitro
models into in vivo platforms for tissue repair.
Mechanical Conditioning
Subjecting stem cells to electrical stimulation and mechanical
loading could be a way to direct their fate and function during
various stages of development, in vitro and in vivo. We are only
beginning to learn about the effects of physical signals on cell
commitment, differentiation, and assembly. Electrical and
mechanical signals are related—for example, muscle cells are
induced to contract by electrical signals—and they both
enhance mass transport of nutrients, most critically oxygen, to
and from the cells. From the early days of tissue engineering,
mechanical conditioning of cells cultured on scaffolds wasexplored based on the premise that the same forces that govern
cell differentiation and tissue development in vivo would also
enhance cell differentiation and tissue development in vitro.
Human ligaments were engineered by applying dynamic tension
and torsion in a specialized bioreactor designed to mimic
mechanical forces in human knee. Interestingly, mechanical
loading alone, without specific growth factors, induced cell
alignment and the accumulation of ligament-specific markers
in favor of alternate differentiation paths into cartilage or bone
(Altman et al., 2002).
Also using a biomimetic paradigm, functional blood vessels
were engineered from adult hMSCs by staged application of
morphogens and pulsatile fluid pressure (Gong and Niklason,
2008). The conditions of mechanical stimulation were designed
to mimic those associated with native vessels: (1) hydrodynamic
shear acting on endothelial cells due to lumen flow and on
smooth muscle cells because of interstitial flow, (2) cyclic pres-
sure, and (3) circumferential and (4) longitudinal stretch. An
elegant approach was recently proposed that enables geom-
etry-force control of stem cell differentiation by cell culture on
geometrically defined patterns (Ruiz and Chen, 2008; Wan
et al., 2010).
Electrical Conditioning
Electrical signals play major roles in stem cell differentiation into
cardiac, vascular, and neural lineages. During early develop-
ment, direct currents gradually give way to the time-varying
currents present in adult tissues. Interestingly, in the case of
injury, the body again reverts to direct currents to drive the repairCell Stem Cell 8, March 4, 2011 ª2011 Elsevier Inc. 257
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same pattern and utilize the developmental and wound-healing
currents. For example, in hESC-derived EBs, the application of
direct current electrical fields enhanced cardiac differentiation,
throughmechanisms involving the generation of reactive oxygen
species (Serena et al., 2009). When subjected to direct currents
similar to those encountered during wound healing, human
adipose-derivedmesenchymal stem cells elongated and aligned
in parallel, disassembled gap junctions, and upregulated the
expression of genes for connexin-43, thrombomodulin, VEGF,
and FGF. The same effects were observed for human epicardial
fat-derived stem cells (Tandon et al., 2009).
To enable high-throughput studies of electrical signals at the
cell level, a microscale bioreactor has been developed with an
interdigitated array of electrodes generated by laser ablation of
a conductive coating on a glass slide (Tandon et al., 2010). The
culture space consisted of an array of 200 mm wide electrodes
positioned at 200 mm distances, and the cells were cultured
between each pair of positive and negative electrodes. When
subjected to pulsatile electrical fields, adipose derived mesen-
chymal stem cells oriented and aligned and increased their
proliferation rate and the number of gap junctions. This simple
and practical culture system allows the study of interactive
effects of surface topography and pulsatile electrical fields on
stem cells, a regime shown to greatly affect the behavior of
cardiac myocytes and cardiac fibroblasts (Au et al., 2007).
Growing Tissues and Organs
Repopulation of Native Tissue Matrix
There is a long clinical history of using decellularized heart
valves, which exhibit an extremely complex shape and structure
that determines its biomechanical function and can be recellular-
ized in vivo for adequate long-term function (Elkins et al., 2001).
About 20 years ago, the tissue-engineering community started to
seek out various ‘‘biological scaffold’’ candidates, produced by
removing cellularmaterial from tissues orwhole organs, because
of their ability tomaintainmuch of the complexities of the compo-
sition, structure, and biomechanics of native tissue (Gilbert et al.,
2006; Badylak, 2007; Ott et al., 2008, 2010; Petersen et al., 2010;
Uygun et al., 2010; Grayson et al., 2009). From blood vessels to
bladder,muscle, bone, and lung, these scaffolds enabled studies
of stem cells in native-like environments and resulted in some
recent remarkable examples of engineering complete organs.
In 2008, a patient was implanted with a bioengineered airway
(Macchiarini et al., 2008) made from allogeneic human trachea.
The donor’s trachea was processed to remove cells and anti-
gens and repopulated by the recipient’s cells, to obtain a graft
that was used to replace the whole left bronchus. The same
year, another group decellularized rodent hearts by coronary
perfusion with detergents, using a method that preserved most
of the composition and architecture of the heart matrix. When
the biological template was reseeded with cells and cultured in
a bioreactor with medium perfusion, the engineered construct
started to beat and, by one month, generated some pumping
function (2% of the adult heart, 16% of the fetal heart) (Ott
et al., 2008).
Most recently, two studies published within a week of each
other reported the engineering of a rodent lung by repopulating
fully decellularized lungs (Ott et al., 2010; Petersen et al.,258 Cell Stem Cell 8, March 4, 2011 ª2011 Elsevier Inc.2010). Remarkably, these engineered lungs functioned in vivo
and persisted for several hours. Lessons learned from using
such scaffolds supplied by nature are leading into the design
of the next generation of synthetic scaffolds with hierarchical
architectures that mimic the structure and function of the native
extracellular matrix (Moutos et al., 2007; Engelmayr et al., 2008).
Customized tissue grafts
Personalized tissue grafts—engineered from the patient’s own
stem cells in the precise anatomical shapes of the defects that
need to be treated—would revolutionize the way we currently
treat large tissue reconstructions. This approach would combine
best of the two worlds: the advantages of living-bone autografts
(the right structure, mechanical and metabolic function, ability to
integrate and remodel) and synthetic materials (precise anatom-
ical shape, off-the-shelf availability). Engineering of living grafts
that would also be anatomically shaped and tailored to the
patient critically depends on our ability to direct stem cell differ-
entiation toward functional tissue assembly within clinically sized
engineered grafts (Grayson et al., 2009).
A novel tissue-engineering system has been established for
the in vitro creation of an entire bone condyle containing viable
cells at physiologic density surrounded by bone matrix (Grayson
et al., 2009). Anatomically-shaped scaffolds with the exact
geometry of a temporomandibular joint (TMJ) were generated
from fully decellularized bone using digitized clinical images,
seeded with human mesenchymal cells, and cultured with inter-
stitial flow of culture medium in an ‘‘anatomical’’ bioreactor
(Figures 3C–3F). For the first time for bone grafts of this size
and complexity, cellswere fully viable andpresent at a physiolog-
ically high density. Flow patterns associated with the complex
geometry of the bone graft provided a unique opportunity to
correlate the architecture of the forming bone with interstitial
flow patterns. In another study, the articular surface of a synovial
joint was regenerated in a rabbit model by homing of endoge-
nous cells into a bioactive scaffold (Lee et al., 2010). We expect
that these approaches, used individually or in combination, will
help provide a variety of anatomically shaped grafts to meet
the needs of a specific patient for a given tissue reconstruction.
Summary and Challenges Ahead
Novel bioengineered culture platforms can provide tight environ-
mental control along with the physiological transport and
signaling and, thereby, enable study of development, regenera-
tion, and disease under conditions that predict the human in vivo
context. In vitro, human stem/progenitor cells are still mostly
studied in systems that lack the structural and signaling specifi-
cation of native tissues, the temporal and spatial sequences of
molecular and physical regulatory factors, and the dynamic
forces and systemic factors provided by blood circulation. In
whole animal models, human cells are studied in an environment
not necessarily representative of their native organism and with
limited control of and insight into cellular responses. As a result,
in vitro studies of human cells/tissues often fail to predict findings
in translational animal models and human clinical studies,
increasing the time and cost and decreasing the effectiveness
of any resulting therapeutic strategies.
The path forward will almost certainly require a deeper under-
standing of how tissues are formed in the body. Lineage tracing
models in mice are providing information about how cell types
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conditions. Animal models now enable durable fluorescent
tagging of particular cell types at particular time points in vivo,
serving as an in vivo equivalent of a pulse-chase experiment.
As such, they can be leveraged to understand more than lineage
relationships. For example, coupling these models with in vivo
imaging technologies permits precise definition of 3D architec-
tural relationships of multiple aspects of organ development
and repair. Further, these novel approaches permit analysis of
cells in particular positions or under particular conditions. As
such, they can be the source of high-density data sets of the
type needed for reconstructing tissues ex vivo.
Full leverage of the biologic systems to bioengineering
contexts requires interaction of biologists and engineers in
ways not yet achieved. The methods of analysis and even the
language of individuals in these disciplines create a cultural
divide that still limits the field. History tells us that such a gap
has existed in other settings before and been successfully
spanned. Enter any genomics laboratory and the collision
between the worlds of computer science and molecular biology
is immediately evident. When the technology of high throughput
sequencing made the potential of unraveling complex genetic
information a reality, visionary individuals in divergent disciplines
came together, driven by opportunity. There is a similar change
currently happening in the field of regenerative medicine. Tools
are becoming available to study with engineering precision the
complex biology of tissues. Materials, including cells, are now
sufficiently plastic to enable recreation of complex in vivo envi-
ronments with significant precision. The leaders in the field and
trainees motivated to take the leap are now catalyzing truly inter-
disciplinary approaches to the study of stem cells and their appli-
cation in regenerative medicine.
In summary, a more profound understanding of the biological
requirements by bioengineers and of the capabilities and limita-
tions of advanced technologies by biologists are among the
barriers we need to overcome in order to define the critical ques-
tions and devise approaches to address these questions. The
interdisciplinary research is now moving the field forward and,
for the very first time, the gap between engineering and biology
is becoming manageable.ACKNOWLEDGMENTS
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